Health and Fitness Health and Fitness
Wed, January 11, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
Magna gibt Prognose bekannt
[ Wed, Jan 11th 2012 ] - Market Wire
Petro Viking Closes Aquisition

Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference


Published on 2012-01-11 06:01:24 - Market Wire
  Print publication without navigation


Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity... -- PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ --

Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference

[ ]

PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: [ ECTE ]), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman & CEO of Echo Therapeutics, will present at Noble Financial Capital Markets' Eighth Annual Equity Conference.

Dr. Mooney will make a presentation to prospective corporate partners and investors on Tuesday, January 17th  at 12:30 PM ET.  The Company's presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida.

At the time of the presentation, a live audio and high-definition video webcast of Echo Therapeutics' presentation and a copy of the presentation materials will be available on the Company's website [ www.echotx.com ] on the Events page or through the Noble Financial websites: [ www.noblefcm.com ] or [ http://www.BOCEM2012.com ].  Echo Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access.  A Microsoft SilverLight viewer (a free download from the presentation link) is required to participate.  The webcast and presentation will also be archived on [ www.echotx.com ] for 30 days following the event.  

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

For More Information:
Christine Olimpio                                                                
Director, Investor Relations & Corporate Communications                        
(215) 717-4104                                                                      

Connect With Us:

- Visit our website at [ www.echotx.com ]

- Follow us on Twitter at [ www.twitter.com/echotx ]

- Join us on Facebook at [ www.facebook.com/echotx ]

 

SOURCE Echo Therapeutics, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.echotx.com ]